184 related articles for article (PubMed ID: 34157778)
1. Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population.
Bernstein-Molho R; Galmor L; Laitman Y; Segev S; Friedman E
Cancer; 2021 Oct; 127(19):3599-3604. PubMed ID: 34157778
[TBL] [Abstract][Full Text] [Related]
2. The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.
Bernstein-Molho R; Laitman Y; Schayek H; Reish O; Lotan S; Haim S; Zidan J; Friedman E
Breast Cancer Res Treat; 2018 Feb; 167(3):697-702. PubMed ID: 29086229
[TBL] [Abstract][Full Text] [Related]
3. Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years.
Bernstein-Molho R; Shhada NA; Laitman Y; Netzer I; Shoval S; Friedman E
Cancer; 2024 Apr; ():. PubMed ID: 38630906
[TBL] [Abstract][Full Text] [Related]
4. Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants.
Castillo C; Artagaveytia N; Brignoni L; Laitman Y; Camejo N; Hernández AL; Krygier G; Cayota A; Delgado L; Friedman E
Mol Genet Genomic Med; 2022 Jun; 10(6):e1928. PubMed ID: 35332707
[TBL] [Abstract][Full Text] [Related]
5. The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations.
Barnes-Kedar I; Bernstein-Molho R; Ginzach N; Hartmajer S; Shapira T; Magal N; Kalis ML; Peretz T; Shohat M; Basel-Salmon L; Friedman E; Bazak L; Goldberg Y
Breast Cancer Res Treat; 2018 Nov; 172(1):151-157. PubMed ID: 30014164
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel.
Laitman Y; Borsthein RT; Stoppa-Lyonnet D; Dagan E; Castera L; Goislard M; Gershoni-Baruch R; Goldberg H; Kaufman B; Ben-Baruch N; Zidan J; Maray T; Soussan-Gutman L; Friedman E
Breast Cancer Res Treat; 2011 Jun; 127(2):489-95. PubMed ID: 20960228
[TBL] [Abstract][Full Text] [Related]
7. [GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN].
Michaelson-Cohen R; Laitman Y; Kedar I; Baris-Feldman H; Reish O; Lieberman S; Bernstein-Molho R; Goldberg Y; Reznick Levi G; Gershoni R; Beller U; Levy-Lahad E; Catan R; Friedman E
Harefuah; 2023 Jun; 162(6):370-375. PubMed ID: 37394440
[TBL] [Abstract][Full Text] [Related]
8. The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
Bernstein-Molho R; Barnes-Kedar I; Ludman MD; Reznik G; Feldman HB; Samra NN; Eilat A; Peretz T; Peretz LP; Shapira T; Magal N; Kalis ML; Yerushalmi R; Vinkler C; Liberman S; Basel-Salmon L; Shohat M; Levy-Lahad E; Friedman E; Bazak L; Goldberg Y
Breast Cancer Res Treat; 2019 Nov; 178(1):231-237. PubMed ID: 31368036
[TBL] [Abstract][Full Text] [Related]
9. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
[TBL] [Abstract][Full Text] [Related]
11. The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.
Gal I; Gershoni Baruch R; Haber D; Dagan E; Eisenberg-Barzilai S; Zidan J; Friedman E
Fam Cancer; 2004; 3(1):11-4. PubMed ID: 15131400
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Abul-Husn NS; Soper ER; Odgis JA; Cullina S; Bobo D; Moscati A; Rodriguez JE; ; ; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
Genome Med; 2019 Dec; 12(1):2. PubMed ID: 31892343
[TBL] [Abstract][Full Text] [Related]
14. Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Rosenthal E; Moyes K; Arnell C; Evans B; Wenstrup RJ
Breast Cancer Res Treat; 2015 Jan; 149(1):223-7. PubMed ID: 25476495
[TBL] [Abstract][Full Text] [Related]
15. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
16. Cancer Susceptibility Genetic Testing in a High-Risk Cohort of Urban Ashkenazi Jewish Individuals.
Nielsen SM; De Simone LM; Olopade OI
J Genet Couns; 2018 Dec; 27(6):1405-1410. PubMed ID: 29946849
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of candidate genes in Israeli male breast cancer cases.
Schayek H; Korach H; Laitman Y; Bernstein-Molho R; Friedman E
Breast Cancer Res Treat; 2018 Jul; 170(2):399-404. PubMed ID: 29560538
[TBL] [Abstract][Full Text] [Related]
18. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
[TBL] [Abstract][Full Text] [Related]
19. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
20. Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel.
Zidan J; Zhou AY; van den Akker J; Laitman Y; Schayek H; Schnaider J; Friedman E
Breast Cancer Res Treat; 2017 Dec; 166(3):881-885. PubMed ID: 28828701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
